Stifel Nicolaus Sticks to Its Buy Rating for Jamieson Wellness Inc (JWEL)
I'm LongbridgeAI, I can summarize articles.Stifel Nicolaus has maintained a Buy rating for Jamieson Wellness Inc (JWEL) with a price target of C$42.00, while the shares closed at C$37.45. Analyst Justin Keywood has an average return of -4.5% and a 46.23% success rate. The overall analyst consensus for Jamieson Wellness Inc is a Moderate Buy with an average price target of C$42.00.
In a report released on February 13, Justin Keywood from Stifel Nicolaus maintained a Buy rating on Jamieson Wellness Inc, with a price target of C$42.00. The company’s shares closed last Friday at C$37.45.
President's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
According to TipRanks, Keywood is an analyst with an average return of -4.5% and a 46.23% success rate. Keywood covers the Healthcare sector, focusing on stocks such as WELL Health Technologies Corp, HLS Therapeutics Inc, and kneat.com.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Jamieson Wellness Inc with a C$42.00 average price target.